Evidence map›Paper›PMID 34178568›Full record

Article3 Biotech2021

The metabolite 5-methyl-1,3-benzenediol and its derivative methyl-2,4-dihydroxy-6-methylbenzoate from the lichen

Ashrini Bhaktavalsala Suresh, Varalakshmi Kilingar Nadumane

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in 3 Biotech, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ashrini Bhaktavalsala SureshDepartment of Biotechnology, School of Sciences, Block-I, Jain (Deemed-to-be-University), #18/3, 9th Main, III Block, Jayanagar, Bangalore, 560 011 India.ORCID 0000-0002-1629-7502
Varalakshmi Kilingar NadumaneDepartment of Biotechnology, School of Sciences, Block-I, Jain (Deemed-to-be-University), #18/3, 9th Main, III Block, Jayanagar, Bangalore, 560 011 India.ORCID 0000-0001-9979-5007
Jain University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nature has been a rich resource of novel anticancer agents, one such source being lichens, which represent the symbiosis between algae and fungi with diverse range of secondary metabolites having therapeutic significance. With respect to this, the present study evaluates the in vitro apoptogenic profile of secondary metabolites from the lichen

Indexed as

Anti-angiogenesisApoptosisGas chromatography–mass spectrometryHigh-performance liquid chromatographyIn ovoIn vitroLichens

Identifiers

PMID34178568
PMCPMC8212346
OpenAlexW3176321416

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.